uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Ipreziv
Withdrawn
Human
Details
EMA number
EMEA/H/C/002517
ATC code
C09CA09
Authorisation
7 December 2011
Withdrawn
27 October 2014
Revision
4
EMA page
Therapeutic indication
Ipreziv is indicated for the treatment of essential hypertension in adults.
MeSH:
Hypertension
Group:
Agents acting on the renin-angiotensin system
Special characteristics
Additional monitoring
Active substances
azilsartan medoxomil
Marketing Authorisation Holder
Takeda Pharma A/S
MAH
Timeline
Filter by authority:
EMA
Ipreziv withdrawn
27 Oct 2014
withdrawn
regulatory
Ipreziv authorised
7 Dec 2011
authorised
regulatory
Ipreziv | uMedical